Diagnosing the Sweet Syndrome
Authors: Philip R. Cohen, Razelle Kurzrock
Journal: Annals of Internal Medicine (1989)

Letters and Corrections1 April 1989Diagnosing the Sweet SyndromePhilip R. Cohen, MD, Razelle Kurzrock, MDPhilip R. Cohen, MDSearch for more papers by this author, Razelle Kurzrock, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-110-7-573_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor:Glaspy and colleagues (1) described low-grade fever, drug-induced neutrophilia, and the enlargement of existing skin lesions in addition to the appearance of new plaques in a 42-year-old woman with hairy cell leukemia and disease-associated erythematous papules of cutaneous vasculitis. The patient was receiving daily subcutaneous injections of recombinant human granulocyte colony-stimulating factor (G-CSF) for neutropenia. The cutaneous and systemic manifestations were attributed to the Sweet syndrome; a histologic evaluation of a lesional skin biopsy, necessary to establish the diagnosis, had not been obtained. On the basis of an unconfirmed diagnosis of the Sweet syndrome, the authors predicted...References1. GlaspyBaldwinRobertson JGP. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med. 1988;109:789-95. LinkGoogle Scholar2. CohenTalpazKurzrock PMR. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol. 1988;6:1887-97. CrossrefMedlineGoogle Scholar3. CohenAlmeidaKurzrock PLR. Acute febrile neutrophilic dermatosis. Am Fam Physician. 1989;39:199-204. MedlineGoogle Scholar4. CohenKurzrock PR. Sweet's syndrome and malignancy. Am J Med. 1987;82:1220-6. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMultiple painful plaques and the Sweet’s syndromeNeutrophilic Dermatosis in Myelodysplastic Syndrome and Chronic Active Hepatitis CNeutrophilic Infiltrates in Panniculitis: Comprehensive Review and Diagnostic Algorithm ProposalA Comprehensive Review of Neutrophilic DiseasesDrug management of neutrophilic dermatosesThe Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 AlphaNeutrophilic DermatosesSweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosisSweet's syndrome and relapsing polychondritis: Is their appearance in the same patient a coincidental occurrence or a bona fide association of these conditions?Sweet's syndrome revisited: a review of disease conceptsSweet??s SyndromeSweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and feverSWEET'S SYNDROMEThe Possible Role of G-CSF in the Pathogenesis of Sweet's SyndromeSweet syndrome in patients with solid tumorsSweet's syndrome as the presenting symptom of hairy cell leukemia with concomitant infection by Mycobacterium kansasiiThe Sweet Syndrome during Therapy with Granulocyte Colony-stimulating FactorJohn W. Park, MD, Bhoomi Mehrotra, MD, Bryan O. Barnett, MD, Ari D. Baron, MD, Alan P. Venook, MDThe pathogenesis of Sweet's syndromeSweet Syndrome in Chronic Myelogenous LeukemiaLEUCOCYTOCLASTIC VASCULITIS DURING GM-CSF THERAPYChronic myelogenous leukemia and sweet syndrome 1 April 1989Volume 110, Issue 7Page: 573-574KeywordsBiopsyDrugsFeversGranulocyte colony stimulating factorLesionsNeutropeniaSubcutaneous injectionsVasculitis Issue Published: 1 April 1989 PDF downloadLoading ...